REG - Hikma Pharmaceutical - Block listing Interim Review
RNS Number : 0786MHikma Pharmaceuticals Plc25 April 2018
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
LEI: 549300BNS685UXH4JI75
Date: 25 April 2018
Name of applicant:
Hikma Pharmaceuticals PLC
Name of scheme:
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
&
Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
&
Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
&
Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
Period of return
From:
1 October 2017
To:
31 March 2018
Balance of unallotted securities under scheme(s) from previous return:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 125,277 ordinary shares of 10 pence
MIP: 187,461 ordinary shares of 10 pence
EIP: 80,044 ordinary shares of 10 pence
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
SOP: 0 ordinary shares of 10 pence
LTIP: 0 ordinary shares of 10 pence
MIP: 800,000 ordinary shares of 10 pence
EIP: 1,200,000 ordinary shares of 10 pence
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
SOP: 0 ordinary shares of 10 pence
LTIP: 18,216 ordinary shares of 10 pence
MIP: 9,345 ordinary shares of 10 pence
EIP: 187,802 ordinary shares of 10 pence
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 107,061 ordinary shares of 10 pence
MIP: 978,116 ordinary shares of 10 pence
EIP: 1,092,242 ordinary shares of 10 pence
Name of contact:
Peter Speirs
Telephone number of contact:
0207 399 2772
Block Listing Six Monthly Return
Stock Option Plan ("SOP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2017
-
-
792,700
Blocklisting return on 01/10/17
01/04/2018
-
-
792,700
Blocklisting return on 01/04/18
Block Listing Six Monthly Return
Long Term Incentive Plan ("LTIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2017
-
-
125,277
Blocklisting return on 01/10/17
17/10/2017
0
4,347
120,930
01/12/2017
0
8,984
111,946
04/12/2017
0
4,885
107,061
01/04/2018
-
-
107,061
Blocklisting return on 01/04/18
Block Listing Six Monthly Return
Management Incentive Plan ("MIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2017
-
-
187,461
Blocklisting return on 01/10/17
20/11/2017
0
6,625
180,836
15/12/2017
0
2,720
178,116
12/03/2018
800,000
0
978,116
01/04/2018
-
-
978,116
Blocklisting return on 01/04/18
Block Listing Six Monthly Return
Executive Incentive Plan ("EIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2017
-
-
80,044
Blocklisting return on 01/10/17
27/02/2018
0
10,298
69,746
12/03/2018
1,200,000
0
1,269,746
20/03/2018
0
9,637
1,260,109
20/03/2018
0
26,090
1,234,019
20/03/2018
0
14,530
1,219,489
20/03/2018
0
38,501
1,180,988
20/03/2018
0
68,346
1,112,642
20/03/2018
0
20,400
1,092,242
01/04/2018
-
-
1,092,242
Blocklisting return on 01/04/18
This information is provided by RNSThe company news service from the London Stock ExchangeENDBLRPGUBWCUPRUBA
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement